2AmodF, HollaVV, OjhaR, PandeyS, YadavR, PalPK. A review of movement disorders in persons living with HIV. Parkinsonism Relat Disord. 2023;114:105774. DOI: 10.1016/j.parkreldis.2023.105774
3CarrollE, Sanchez-RamosJ. Hyperkinetic movement disorders associated with HIV and other viral infections. Handb Clin Neurol. 2011;100:323–34. DOI: 10.1016/B978-0-444-52014-2.00025-2
6GargRK, PandeyS, SinghalS. Toxoplasmosis-Associated Extrapyramidal and Movement Disorders: A Systematic Review. PROSPERO 2025 CRD420251119727. Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251119727.
7AertsR, MehraV, GrollAH, MartinoR, LagrouK, RobinC, PerruccioK, BlijlevensN, NucciM, SlavinM, BretagneS, CordonnierC, European Conference on Infections in Leukaemia group. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022. Lancet Infect Dis. 2024;24(5):e291–e306. DOI: 10.1016/S1473-3099(23)00495-4
8HeyG, HuW, WongJ, TsuboiT, BurnsMR, Ramirez-ZamoraA. Evolving Concepts in Our Understanding and Treatment of Holmes Tremor, Over 100 Years in the Making. Tremor Other Hyperkinet Mov (N Y). 2022;12:18. DOI: 10.5334/tohm.683
9The Movement Disorder Society. About Movement Disorders: View clinical information, resources, tools and education about common movement disorders. Downloaded from https://www.movementdisorders.org/MDS/About/Movement-Disorder-Overviews.htm. Assessed on 31th July, 2025.
10MuradMH, SultanS, HaffarS, BazerbachiF. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63. DOI: 10.1136/bmjebm-2017-110853
12AlvesD, SobrosaP, Morais PassosR, SilvaF, FerreiraA, Corga da SilvaR, SilvaD. Cerebral Toxoplasmosis Mimicking a Brain Neoplasm in an Inaugural HIV-Positive Patient: The Importance of Early Decision-Making and Background Assessment in the Emergency Department. Cureus. 2025;17(1):e76936. DOI: 10.7759/cureus.76936
13DiazMM, McCutchanJA, CresciniM, TangB, FranklinD, LetendreSL, HeatonRK, BhartiAR. Longitudinal study of cognitive function in people with HIV and toxoplasmic encephalitis or latent toxoplasma infection. AIDS. 2024;38(15):2021–2029. DOI: 10.1097/QAD.0000000000003992
17ZhouZ, ZhouR, LiK, WeiW, ZhangZ, ZhuY, LuanR. The Association between Toxoplasma gondii Infection and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2019;2019:8186017. DOI: 10.1155/2019/8186017
18FallahiS, RostamiA, BirjandiM, ZebardastN, KheirandishF, SpotinA. Parkinson’s disease and Toxoplasma gondii infection: Sero-molecular assess the possible link among patients. Acta Trop. 2017;173:97–101. DOI: 10.1016/j.actatropica.2017.06.002
20CelikT, AltunisikE, YarTM, GulT, Kasko AriciY, KaramanU. A new perspective on essential tremor: the potential etiologic role of Toxoplasma gondii and Toxocara spp. Int J Environ Health Res. 2025;35(7):1764–1771. DOI: 10.1080/09603123.2024.2404480
21TaherianfardM, RiyahiM, RazaviM, BavandiZ, Eskandari RoozbahaniN, NamavariMM. The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson’s Disease Can Be Affected by Toxoplasma gondii Infection. Biomed Res Int. 2020;2020:2546365. DOI: 10.1155/2020/2546365